405 related articles for article (PubMed ID: 19061651)
1. [Oral ulcers in kidney allograft recipients treated with sirolimus].
Fricain JC; Cellerié K; Sibaud V; Catros S; Taïeb A; Merville P
Ann Dermatol Venereol; 2008 Nov; 135(11):737-41. PubMed ID: 19061651
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
Chueh SC; Kahan BD
Transplantation; 2003 Jul; 76(2):375-82. PubMed ID: 12883196
[TBL] [Abstract][Full Text] [Related]
3. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
van Gelder T; ter Meulen CG; Hené R; Weimar W; Hoitsma A
Transplantation; 2003 Mar; 75(6):788-91. PubMed ID: 12660502
[TBL] [Abstract][Full Text] [Related]
4. Center experience in liver transplantation (LTX): management of dermal side effects caused by sirolimus.
Schaffellner S; Jakoby E; Kniepeiss D; Stadlbauer V; Duller D; Iberer F; Tscheliessnigg KH
Int Immunopharmacol; 2005 Jan; 5(1):137-40. PubMed ID: 15589473
[TBL] [Abstract][Full Text] [Related]
5. Impact of variability of sirolimus trough level on chronic allograft nephropathy.
Wu MJ; Shu KH; Lian JD; Yang CR; Cheng CH; Chen CH
Transplant Proc; 2008 Sep; 40(7):2202-5. PubMed ID: 18790192
[TBL] [Abstract][Full Text] [Related]
6. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic dystrophy associated with sirolimus therapy.
Molina MG; Diekmann F; Burgos D; Cabello M; Lopez V; Oppenheimer F; Navarro A; Campistol J
Transplantation; 2008 Jan; 85(2):290-2. PubMed ID: 18212635
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus interferes with iron homeostasis in renal transplant recipients.
Maiorano A; Stallone G; Schena A; Infante B; Pontrelli P; Schena FP; Grandaliano G
Transplantation; 2006 Oct; 82(7):908-12. PubMed ID: 17038905
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-induced aphthous ulcers which disappeared with conversion to everolimus.
Ram R; Swarnalatha G; Neela P; Dakshinamurty KV
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):819-20. PubMed ID: 18711306
[No Abstract] [Full Text] [Related]
10. [Mouth ulcers in patients receiving tacrolimus].
Macario-Barrel A; Tanasescu S; Courville P; Redonnet M; Cordel N; Lauret P; Joly P
Ann Dermatol Venereol; 2001 Dec; 128(12):1327-9. PubMed ID: 11908135
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus oral ulcer with Cedecea davisae superinfection.
Mawardi H; Pavlakis M; Mandelbrot D; Woo SB
Transpl Infect Dis; 2010 Oct; 12(5):446-50. PubMed ID: 20525018
[TBL] [Abstract][Full Text] [Related]
12. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A
Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118
[TBL] [Abstract][Full Text] [Related]
13. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation.
King-Biggs MB; Dunitz JM; Park SJ; Kay Savik S; Hertz MI
Transplantation; 2003 May; 75(9):1437-43. PubMed ID: 12792493
[TBL] [Abstract][Full Text] [Related]
14. Generalized lymphedema in a sirolimus-treated renal transplant patient.
De Bartolomeis C; Collini A; Rumberger B; Barni R; Ruggieri G; Bernini M; Carmellini M
Clin Transplant; 2008; 22(2):254-7. PubMed ID: 18339149
[TBL] [Abstract][Full Text] [Related]
15. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
[TBL] [Abstract][Full Text] [Related]
16. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy.
Yakupoglu YK; Buell JF; Woodle S; Kahan BD
Transplant Proc; 2006 Mar; 38(2):358-61. PubMed ID: 16549120
[TBL] [Abstract][Full Text] [Related]
17. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
[TBL] [Abstract][Full Text] [Related]
18. Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome--a single-centre experience and review of the literature.
Weiner SM; Sellin L; Vonend O; Schenker P; Buchner NJ; Flecken M; Viebahn R; Rump LC
Nephrol Dial Transplant; 2007 Dec; 22(12):3631-7. PubMed ID: 17611248
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure following kidney transplantation associated with myoglobinuria in patients treated with rapamycin.
Pelletier R; Nadasdy T; Nadasdy G; Satoskar A; Tewari AK; Cotrill J; Henry M; Rajab A; Ferguson R
Transplantation; 2006 Sep; 82(5):645-50. PubMed ID: 16969287
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.
Garrean S; Massad MG; Tshibaka M; Hanhan Z; Caines AE; Benedetti E
Clin Transplant; 2005 Oct; 19(5):698-703. PubMed ID: 16146565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
